When was Innopharma founded?

Innopharma was founded in 2005 and raised its 1st funding round 6 years after it was founded.

Where is Innopharma located?

Innopharma is headquartered in Piscataway, United States.

How many employees does Innopharma have?

As of May 31, 2026, the latest employee count at Innopharma is 101444.

Is Innopharma a funded company?

Innopharma is a funded company, having raised a total of $23M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 01, 2011.

When was the latest funding round of Innopharma?

Innopharma's latest funding was a $***** Conventional Debt round on Nov 13, 2013, with participation from 0 investor. Its primary sector is Traditional Pharmaceuticals. Globally, the Traditional Pharmaceuticals sector has seen $1.29B in funding in 2026 to date.

Where does Innopharma rank among its competitors?

Innopharma ranks 6th amongst 89 active competitors, of which 5 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Exela Pharma, which secured $28.3M in Sep, 2025.

Who are the top competitors of Innopharma?

Innopharma's top competitors include Gufic Group, Sagent Pharma and JAMP Pharma. Among them, Exela Pharma secured the most recent funding round in September, 2025.

Innopharma - 2026 Company Profile, Team, Funding & Competitors

Innopharma is an acquired company based in Piscataway (United States), founded in 2005 by Sriram Ramanathan. It operates as a Manufacturer of injectable pharmaceutical products. Innopharma has raised $23M in funding from Thomas, McNerney & Partners. The company has 89 active competitors, including 5 funded and 24 that have exited. Its top competitors include companies like Gufic Group, Sagent Pharma and JAMP Pharma.

Company Details

InnoPharma develops injectable specialty pharmaceutical products. The company offers generic products on the market, indicated for use in a wide range of therapeutic areas including respiratory diseases, oncology, antipsychotics, neural diseases, cardiovascular and hormones. In addition, the company has products in the pipeline in various stages of development.

Key Metrics

Founded Year

2005

Location

Piscataway, United States

Stage

Acquired

Total Funding

$23M in 3 rounds

Latest Funding Round

Conventional Debt, Nov 13, 2013, $*****

Investors

Thomas, McNerney & Partners & 2 more

Ranked

6^th among 89 active competitors

Employee Count

101,444 as on May 31, 2026

Similar Companies

Gufic Group & 98 more

Exit Details

Acquired by Pfizer (Jul 16, 2014)

View Innopharma's full profile

Innopharma got acquired by Pfizer on Jul 16, 2014.

Click here to take a look at Innopharma's acquisition in detail

Innopharma has raised a total funding of $23M over 3 rounds. Its first funding round was on Dec 01, 2011. Innopharma has 3 institutional investors.

Here is the list of recent funding rounds of Innopharma:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 13, 2013	9177149	Conventional Debt	5566034	3809164	5124439	7219908
Jun 07, 2012	6404496	Series A	8434190	5912310	6024630	Comerica & 1 more
Dec 01, 2011	7481515	Series A	5633463	7388505	Thomas, McNerney & Partners	6826884

Access funding benchmarks and valuations. Sign up today!

View details of Innopharma's funding rounds and investors

The founders of Innopharma is Sriram Ramanathan.

Here are the details of Innopharma's key team members:

Sriram Ramanathan: Co-Founder & COO of Innopharma.

View details of Innopharma's Founder profiles and Board Members

Innopharma's employee count trend

Innopharma has 101,444 employees as of May 26. Here is Innopharma's employee count trend over the years:

Uncover Innopharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Innopharma include Gufic Group, Sagent Pharma and JAMP Pharma. Here is the list of Top 10 competitors of Innopharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gufic Group 1970, Mumbai (India), Public	Manufacturer of lyophilized injections and pharmaceutical products	-	-	58/100
2nd	Sagent Pharma 2006, Schaumburg (United States), Acquired	Provider of injectable generic pharmaceuticals	$153M	Zhejiang Hisun Pharmaceuticals, MidCap Financial ... & 3 others	51/100
3rd	JAMP Pharma 1988, Boucherville (Canada), Late Stage	Manufacturer of injectables	-	Fonds de solidarite FTQ	51/100
4th	ImprimisRx 1998, Roxbury Township (United States), Seed	Developer of proprietary sterile and topical drug formulations	$80K	-	50/100
5th	Kelun Pharmaceutical 1996, Chengdu (China), Public	Manufacturer of pharmaceutical products and related services	-	Yonghua Capital	49/100
6th	Innopharma 2005, Piscataway (United States), Acquired	Manufacturer of injectable pharmaceutical products	$23M	Comerica, NXT Capital & 1 others	49/100
7th	Nanolek 2011, Moscow (Russia), Late Stage	Manufacturer of biopharmaceuticals and vaccines	$43.7M	Sberbank, Rusnano	48/100
8th	Otsuka Pharmaceutical India 2012, Ahmedabad (India), Unfunded	Manufacturer of intravenous infusions and clinical nutrition products	-	-	48/100
9th	Exela Pharma 2005, Lenoir (United States), Series B	Manufacturer of sterile injectable pharmaceutical products and CDMO services	$6.67M	Trinity Capital, Baruch Future Ventures & 3 others	46/100
10th	Amphastar Pharmaceuticals 1996, Rancho Cucamonga (United States), Public	Manufacturer of injectable and inhalation products	-	YFY, Yet2ventures & 2 others	46/100